Document Detail


Ethics and practice: alternative designs for phase III randomized clinical trials.
MedLine Citation:
PMID:  10227416     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
For decades, biostatisticians have developed and refined the methodology for clinical trials with the intent of giving trial participants a better representation than traditional, equal-allocation, fixed sample-size designs. Despite these methodologic advances and ethical advantages, alternative or data-dependent designs for phase III clinical trials, including sequential designs, Bayesian methods, and adaptive designs, have not been widely adopted in practice. We attempt to characterize situations under which these designs are feasible and desirable from ethical and logistical standpoints. In particular, we describe the role of individual and collective ethics in designing clinical trials and argue that greater attention should be paid to the former. We give examples of those alternative designs that have been used in practice, including discussion of their strengths and shortcomings. We conclude that alternative designs are applicable in limited classes of trials and that investigators should consider them more often when planning clinical trials.
Authors:
C R Palmer; W F Rosenberger
Related Documents :
20144396 - Plasma-generating glucose monitor accuracy demonstrated in an animal model.
8236756 - Current status of models for testing antibiotic residues.
20824446 - Clinical trials and rare diseases.
22035856 - Spatial autocorrelation calculations of the nine malignant neoplasms in taiwan in 2005-...
20461596 - Fractal pharmacokinetics.
14747676 - Use of combined measures from capillary blood to assess iron deficiency in rural kenyan...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Controlled clinical trials     Volume:  20     ISSN:  0197-2456     ISO Abbreviation:  Control Clin Trials     Publication Date:  1999 Apr 
Date Detail:
Created Date:  1999-06-17     Completed Date:  1999-06-17     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8006242     Medline TA:  Control Clin Trials     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  172-86     Citation Subset:  E; IM    
Affiliation:
Centre for Applied Medical Statistics, Department of Community Medicine, Institute of Public Health, University of Cambridge, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bayes Theorem
Biometry
Clinical Trials, Phase III as Topic / classification,  methods*
Cross-Over Studies
Ethics, Medical*
Feasibility Studies
Humans
Linear Models
Medical Informatics
Practice Guidelines as Topic
Random Allocation
Randomized Controlled Trials as Topic / classification,  methods*
Research Design*
Sample Size
Selection Bias
Grant Support
ID/Acronym/Agency:
R29-DK51017-02/DK/NIDDK NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Zelen randomization: attitudes of parents participating in a neonatal clinical trial.
Next Document:  Improving informed consent in clinical trials: a duty to experiment.